...
首页> 外文期刊>Clinical and laboratory haematology >Development of anti-VWF antibody in a patient with severe haemophilia A following the development of high-grade non-Hodgkin's lymphoma.
【24h】

Development of anti-VWF antibody in a patient with severe haemophilia A following the development of high-grade non-Hodgkin's lymphoma.

机译:重度非霍奇金淋巴瘤发生后,严重V型血友病患者中抗VWF抗体的发展。

获取原文
获取原文并翻译 | 示例
           

摘要

A 9-year-old-boy with severe haemophilia A (factor VIII < 1%) developed colicky abdominal pain with swelling in the left iliac fossa for 4 weeks. His LDH level was 1423 IU/l (normal range < 220 IU/l) and his uric acid, 6.8 mg/dl. A computerised tomography (CT) scan of the abdomen demonstrated a tumour of the terminal ileum and mild hepatosplenomegaly. Pre-operative screening for factor VIII inhibitor was negative. Post-operatively, the patient needed high doses of factor VIII to maintain haemostasis. The tumour was found to be a high-grade lymphoma of Burkitt's type. He recovered from his operation and chemotherapy was commenced. Investigations demonstrated an anti-von Willebrand factor (VWF) antibody. He subsequently relapsed and died of progressive disease. Development of anti-VWF antibody in lymphoma is well known, but development of this antibody in a haemophilia A patient developing lymphoma has not been reported. The present case shows that antibody to VWF should be considered as a possible reason for an increased factor VIII requirement in such patients.
机译:一个9岁的男孩患有严重的A型血友病(因子VIII <1%),出现腹部绞痛,左窝肿胀持续4周。他的LDH水平为1423 IU / l(正常范围<220 IU / l),尿酸为6.8 mg / dl。腹部的计算机断层扫描(CT)扫描显示回肠末端肿瘤和轻度肝脾肿大。术前筛查的factor因子抑制剂为阴性。术后,患者需要高剂量的VIII因子来维持止血。发现该肿瘤是伯基特型的高度淋巴瘤。他从手术中康复,开始了化疗。研究证明了一种抗von Willebrand因子(VWF)抗体。他随后复发并死于进行性疾病。抗VWF抗体在淋巴瘤中的发展是众所周知的,但在血友病中该抗体的发展尚未报道过正在发展为淋巴瘤的患者。目前的情况表明,应将针对VWF的抗体视为此类患者中VIII因子需求增加的可能原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号